Organization
Wake Forest Baptist Health
3 abstracts
Abstract
Detection of peritoneal metastases during cytoreductive surgery using pegsitacianine, a pH sensitive imaging agent: Final results from a phase 2 study.Org: Wake Forest University Department of General Internal Medicine, Wake Forest Baptist Health, University of Pennsylvania, OncoNano Medicine, Allegheny Health Network Cancer Institute,
Abstract
Multi-institutional study of reirradiation for recurrent high grade glioma.Org: Alexander T. Augusta Military Medical Center, Wake Forest Baptist Health, Wake Forest School of Medicine, Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Department of Radiation Oncology, Washington University School of Medicine in St. Louis,
Abstract
Primary analysis of STARTAR: A phase 2 salvage trial of androgen receptor (AR) inhibition with androgen deprivation therapy (ADT) and apalutamide with radiation therapy (RT) followed by docetaxel in men with PSA recurrent prostate cancer (PC) after radical prostatectomy (RP).Org: University of Texas Southwestern Medical Center, Duke University School of Medicine, Department of Head and Neck Surgery & Communication Sciences, Durham, NC, Duke University Cancer Institute, Weill Cornell Medicine and NewYork-Presbyterian Hospital, New York, NY, Wake Forest Baptist Health,